Amphastar Pharmaceuticals (AMPH) EBT Margin Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) EBT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.64 Mn | 644.51 Mn | 93.47 Mn | -156.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -156.00 |
| Mar 31, 2026 | -1,810.00 |
| Dec 31, 2025 | -1,313.00 |
| Sep 30, 2025 | -760.00 |
| Jun 30, 2025 | 380.00 |
| Mar 31, 2025 | -602.00 |
| Dec 31, 2024 | 110.00 |
| Sep 30, 2024 | -862.00 |
| Jun 30, 2024 | 1,356.00 |
| Mar 31, 2024 | 2,290.00 |
| Dec 31, 2023 | -7,190.00 |
| Sep 30, 2023 | 2,676.00 |
| Jun 30, 2023 | 2,427.00 |
| Mar 31, 2023 | 1,712.00 |
| Dec 31, 2022 | 891.00 |
| Sep 30, 2022 | 1,684.00 |
| Jun 30, 2022 | -5,854.00 |
| Mar 31, 2022 | 2,867.00 |
| Dec 31, 2021 | 2,181.00 |
| Sep 30, 2021 | 3,015.00 |